Positive COPD Data Allows Forest To File For Approval of Eklira in 2011
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest Laboratories and Spain's Almirall report positive late-stage data for their COPD drug, paving the way for 2011 regulatory filings in the U.S. and EU.